Key result
Long-term intravenous infusion of atrial natriuretic peptide in conscious dogs decreased mean arterial pressure from 90 to 74 mm Hg by day 4, with no significant long-term effect on GFR.
Why the study?
Does intravenous infusion of atrial natriuretic peptide reduce mean arterial pressure and increase sodium excretion in conscious dogs?
Does intravenous infusion of atrial natriuretic peptide reduce mean arterial pressure and increase sodium excretion in conscious dogs?
Long-term infusion of atrial natriuretic peptide in conscious dogs produces a sustained reduction in mean arterial pressure despite only transient effects on sodium excretion and glomerular filtration rate.
Answers are grounded in this paper and cite their sources.
ANP effects in dogs warrant clinical caution; leaves open translation to human hypertension pending prospective trials.
The present study was designed to examine the short-term and long-term effects of increased plasma levels of atrial natriuretic peptide on the glomerular filtration rate, sodium excretion, and arterial pressure. Intravenous infusion of synthetic atrial natriuretic peptide (2 micrograms/kg/bolus, 50 ng/kg/min continuous infusion) for 45 minutes in six conscious dogs increased plasma levels of immunoreactive atrial natriuretic peptide from 69 +/- 10 to 233 +/- 14 pg/ml. Short-term increases in plasma levels of atrial natriuretic peptide increased the glomerular filtration rate from 53 +/- 15 to 82 +/- 16 ml/min and increased sodium excretion from 74.4 +/- 32.6 to 146.9 +/- 38.1 microEq/min. Mean arterial pressure decreased slightly, from 88 +/- 3 to 83 +/- 3 mm Hg, whereas no changes occurred in plasma renin activity (2.0 +/- 0.6 to 1.6 +/- 0.8 ng of angiotensin I per milliliter per hour) or plasma aldosterone concentration (6.9 +/- 2.3 to 8.1 +/- 3.9 ng/dl). To determine whether the short-term effects of atrial natriuretic peptide on the glomerular filtration rate and sodium excretion lead to a sustained reduction in mean arterial pressure, atrial natriuretic peptide (50 ng/kg/min) was infused intravenously for 5 days in six conscious dogs. Long-term infusion increased plasma levels of immunoreactive atrial natriuretic peptide from 27 +/- 5 to 292 +/- 31 pg/ml. The infusion caused only a transient increase in sodium excretion and had no significant long-term effect on the glomerular filtration rate. Mean arterial pressure decreased from 90 +/- 3 to 74 +/- 3 and 75 +/- 4 mm Hg by Days 4 and 5 of the infusion.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Granger et al. (1986) studied this question. Synthetic atrial natriuretic peptide vs. Baseline was evaluated on Glomerular filtration rate, sodium excretion, and mean arterial pressure. Long-term intravenous infusion of atrial natriuretic peptide in conscious dogs decreased mean arterial pressure from 90 to 74 mm Hg by day 4, with no significant long-term effect on GFR.
Synapse has enriched 10 related papers. Consider them for comparative context: